Neal has proven leadership skills and strong track record of success in US and Global Commercial leadership positions, with extensive experience in shaping commercial strategy, executing strategic portfolio choices and launching products.
Neal is currently the Chief Business Officer for Eclipse Life Sciences, a company developing therapeutic compounds to treat ophthalmological disease, targeting both front-of-the-eye diseases, such as uveitis and dry eye as well as back-of-the-eye diseases such as wet or dry macular degeneration or diabetic retinopathy.
Prior to his current role, he was the Vice President and Head of Marketing at Vyluma, Inc. where he was responsible for all Marketing activities across the entire Vyluma portfolio of ophthalmic products. He led the creation and execution of all marketing activities across Vyluma’s portfolio of products focused on areas of high unmet need including addressing the pediatric myopia epidemic.
Prior to Vyluma, Neal was at Bristol-Myers Squibb most recently as the Worldwide Cardiovascular Commercial Lead for the marketing and development efforts for the early and late-stage cardiovascular portfolio. While at BMS, Neal also worked on the global launch of Eliquis and on Plavix. Prior to BMS, Neal had a series of commercial and marketing roles at Sanofi, The Medicines Company and Abbvie.